University of Colorado Boulder 1002176421

Brilliant Violet 605™ anti-T-bet Antibody

On August 14, 2025, the University of Colorado Boulder awarded a contract to BioLegend Inc. for the procurement of 1 unit of Brilliant Violet 605™ anti-T-bet Antibody, with a total obligated and award amount of $242. This single-transaction purchase is part of an existing procurement and involves a product used possibly in biomedical research or laboratory analysis. No specific contract end date is provided. The award is categorized under research or medical supplies for a higher education institution.

Description

Brilliant Violet 605™ anti-T-bet Antibody